| Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer SS Myatt, J Wang, LJ Monteiro, M Christian, KK Ho, L Fusi, RE Dina, ... Cancer research 70 (1), 367-377, 2010 | 432 | 2010 |
| Incomplete excision of cervical intraepithelial neoplasia and risk of treatment failure: a meta-analysis S Ghaem-Maghami, S Sagi, G Majeed, WP Soutter The lancet oncology 8 (11), 985-993, 2007 | 374 | 2007 |
| Incomplete excision of cervical precancer as a predictor of treatment failure: a systematic review and meta-analysis M Arbyn, CWE Redman, F Verdoodt, M Kyrgiou, M Tzafetas, ... The Lancet Oncology 18 (12), 1665-1679, 2017 | 358 | 2017 |
| Presurgical diagnosis of adnexal tumours using mathematical models and scoring systems: a systematic review and meta-analysis J Kaijser, A Sayasneh, K Van Hoorde, S Ghaem-Maghami, T Bourne, ... Human reproduction update 20 (3), 449-462, 2014 | 279 | 2014 |
| Randomized trial of cytoreductive surgery for relapsed ovarian cancer P Harter, J Sehouli, I Vergote, G Ferron, A Reuss, W Meier, S Greggi, ... New England Journal of Medicine 385 (23), 2123-2131, 2021 | 245 | 2021 |
| Standardized approach for imaging and measuring Cesarean section scars using ultrasonography O Naji, Y Abdallah, AJ Bij De Vaate, A Smith, A Pexsters, C Stalder, ... Ultrasound in obstetrics & gynecology 39 (3), 252-259, 2012 | 239 | 2012 |
| Indications for caesarean section Z Penn, S Ghaem-Maghami Best practice & research Clinical obstetrics & gynaecology 15 (1), 1-15, 2001 | 239 | 2001 |
| The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome EJ Crosbie, NAJ Ryan, MJ Arends, T Bosse, J Burn, JM Cornes, ... Genetics in Medicine 21 (10), 2390-2400, 2019 | 231 | 2019 |
| Randomized controlled phase III study evaluating the impact of secondary cytoreductive surgery in recurrent ovarian cancer: AGO DESKTOP III/ENGOT ov20. A Du Bois, I Vergote, G Ferron, A Reuss, W Meier, S Greggi, PT Jensen, ... Journal of Clinical Oncology 35 (15_suppl), 5501-5501, 2017 | 223 | 2017 |
| Endometrial cancer S Saso, J Chatterjee, E Georgiou, AM Ditri, JR Smith, S Ghaem-Maghami Bmj 343, 2011 | 208 | 2011 |
| Randomized phase III study to evaluate the impact of secondary cytoreductive surgery in recurrent ovarian cancer: Final analysis of AGO DESKTOP III/ENGOT-ov20. A Du Bois, J Sehouli, I Vergote, G Ferron, A Reuss, W Meier, S Greggi, ... Journal of Clinical Oncology 38 (15_suppl), 6000-6000, 2020 | 181 | 2020 |
| Human uterine transplantation: a review of outcomes from the first 45 cases BP Jones, S Saso, T Bracewell‐Milnes, MY Thum, J Nicopoullos, ... BJOG: An International Journal of Obstetrics & Gynaecology 126 (11), 1310-1319, 2019 | 170 | 2019 |
| The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer TG Hopkins, M Mura, HA Al-Ashtal, RM Lahr, N Abd-Latip, K Sweeney, ... Nucleic acids research 44 (3), 1227-1246, 2016 | 169 | 2016 |
| The surgical intelligent knife distinguishes normal, borderline and malignant gynaecological tissues using rapid evaporative ionisation mass spectrometry (REIMS) DL Phelps, J Balog, LF Gildea, Z Bodai, A Savage, MA El-Bahrawy, ... British journal of cancer 118 (10), 1349-1358, 2018 | 166 | 2018 |
| Ovarian cancer immunotherapy using PD‐L1 siRNA targeted delivery from folic acid‐functionalized polyethylenimine: strategies to enhance T cell killing PY Teo, C Yang, LM Whilding, AC Parente‐Pereira, J Maher, AJT George, ... Advanced healthcare materials 4 (8), 1180-1189, 2015 | 166 | 2015 |
| Programmed death ligand-1 over-expression correlates with malignancy and contributes to immune regulation in ovarian cancer CJ Maine, NHA Aziz, J Chatterjee, C Hayford, N Brewig, L Whilding, ... Cancer immunology, immunotherapy 63, 215-224, 2014 | 155 | 2014 |
| Multicentre external validation of IOTA prediction models and RMI by operators with varied training A Sayasneh, L Wynants, J Preisler, J Kaijser, S Johnson, C Stalder, ... British journal of cancer 108 (12), 2448-2454, 2013 | 147 | 2013 |
| Preclinical in vivo modeling of cytokine release syndrome induced by ErbB-retargeted human T cells: identifying a window of therapeutic opportunity? SJC Van der Stegen, DM Davies, S Wilkie, J Foster, JK Sosabowski, ... The Journal of Immunology 191 (9), 4589-4598, 2013 | 140 | 2013 |
| Mechanism and functional consequences of loss of FOXO1 expression in endometrioid endometrial cancer cells T Goto, M Takano, A Albergaria, J Briese, KM Pomeranz, B Cloke, L Fusi, ... Oncogene 27 (1), 9-19, 2008 | 122 | 2008 |
| Hydrophobic modification of low molecular weight polyethylenimine for improved gene transfection PY Teo, C Yang, JL Hedrick, AC Engler, DJ Coady, S Ghaem-Maghami, ... Biomaterials 34 (32), 7971-7979, 2013 | 121 | 2013 |
